Moxifloxacin Ophthalmic

282 interactions 387 cited references

Also sold as: Moxeza® Vigamox Vigamox®

About Moxifloxacin Ophthalmic

Moxifloxacin ophthalmic solution is a fluoroquinolone antibiotic used to treat bacterial eye infections like pink eye. Read the full Moxifloxacin Ophthalmic drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir Sparfloxacin

12 Contraindicated 251 Major 19 Moderate

All (282) Contraindicated (12) Major (251) Moderate (19)

Major

Moxifloxacin Ophthalmic Crizotinib Xalkori An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Cyclobenzaprine Amrix An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Dabrafenib Tafinlar An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Dapagliflozin Farxiga Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Dasatinib Phyrago Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Deflazacort Emflaza An increased risk of tendon rupture Details Moxifloxacin Ophthalmic Degarelix Firmagon Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Delamanid Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Desflurane Suprane An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Desipramine Norpramin Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Dexamethasone An increased risk of tendon rupture Details Moxifloxacin Ophthalmic Dexmedetomidine Dexased Increased risk of cardiac arrhythmias Details Moxifloxacin Ophthalmic Disopyramide Norpace Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Dofetilide Tikosyn Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Dolasetron Anzemet Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Domperidone Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Donepezil Adlarity Increased risk of QT-interval prolongation and torsade de pointes Details Moxifloxacin Ophthalmic Dordaviprone An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Doxepin Prudoxin Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Droperidol Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Dulaglutide Trulicity Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Ebastine Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Efavirenz An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Empagliflozin Glyxambi® (as a combination product containing Empagliflozin and Linagliptin) Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Encorafenib Braftovi Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Eribulin Halaven Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Ertugliflozin Steglatro Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Erythromycin Erythrocin Stearate Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Escitalopram Lexapro An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Etrasimod Velsipity Increased risk of transient reduction in heart rate, AV conduction, QT interval prolongation and an increased risk of torsade de p... Details Moxifloxacin Ophthalmic Exenatide Bydureon Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Famotidine Calmicid Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Felbamate Felbatol Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Fexinidazole An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Fingolimod Gilenya Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Flecainide Tambocor® Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Fluconazole Diflucan Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Fludrocortisone An increased risk of tendon rupture Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.